SCHEMBL30808197

SCHEMBL30808197

Cc1cc(Br)c2nc(N3CCC3)cnc2c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MET P08581 8/20 0.50
▸ HRH4 Q9H3N8 3/20 0.39
▸ HCRTR2 O43614 2/20 0.37
▸ HCRTR1 O43613 1/20 0.37
▸ HTR3A P46098 1/20 0.37
▸ L3MBTL1 Q9Y468 3/20 0.37
▸ KDM4E B2RXH2 3/20 0.35
▸ GAA P10253 3/20 0.35
▸ TDP1 Q9NUW8 1/20 0.35
▸ NPC1 O15118 2/20 0.34
▸ MAPT P10636 2/20 0.34
▸ RAB9A P51151 2/20 0.34
▸ ALDH1A1 P00352 1/20 0.34
▸ HPGD P15428 1/20 0.34
▸ NFKB1 P19838 1/20 0.34
▸ HTT P42858 1/20 0.34
▸ NFKB2 Q00653 1/20 0.34
▸ RELA Q04206 1/20 0.34
▸ SMN1; SMN2 Q16637 1/20 0.34
▸ NPSR1 Q6W5P4 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30808192 0.97 MET (0.50) METHRH4HCRTR2HCRTR1HTR3A
SCHEMBL30808201 0.96 MET (0.49) METHRH4HCRTR2HCRTR1HTR3A
SCHEMBL30808177 0.87 MET (0.47) METKDM4EGAATDP1NPC1
SCHEMBL18739629 0.87 MET (0.47) METKDM4EGAATDP1NPC1
SCHEMBL30808150 0.85 MET (0.41) METHRH4HCRTR2HCRTR1HTR3A
SCHEMBL30808190 0.80 MAPT (0.60) METHRH4HTR3AKDM4EGAA
SCHEMBL30808227 0.78 MET (0.46) METHRH4HTR3A
SCHEMBL18739631 0.76 ALDH1A1 (0.43) METHRH4KDM4EGAATDP1
SCHEMBL30808172 0.74 MET (0.46) METL3MBTL1KDM4EGAATDP1
SCHEMBL30808162 0.74 SMN1; SMN2 (0.48) METL3MBTL1KDM4EGAATDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024026419-A1 QUINOXALINE DERIVATIVES AS PIK3 ALPHA MODULATORS BLACK DIAMOND THERAPEUTICS, INC. (US) 2024-02-01 — — WO disclosed
Send feedback